Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Aragon Pharmaceuticals, Inc.

Clinical trials sponsored by Aragon Pharmaceuticals, Inc., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Can a new drug combo stop prostate cancer from spreading? Results expected Mar 2027 (estimated)

Browse trials soon ready across all sponsors →

Not yet finished but already full! 7 Completed 1

New pill shows promise against tough prostate cancer

Disease control Completed

This study tested a drug called ARN-509 in 127 men with advanced prostate cancer that had stopped responding to standard hormone therapy. The goal was to find a safe dose and see if the drug could lower PSA levels, a marker of cancer activity. The drug works by blocking male horm…

Phase 1/2 • Sponsor: Aragon Pharmaceuticals, Inc. • Aim: Disease control

Last updated Jun 27, 2026 13:02 UTC